ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BHVN Biohaven Ltd

40.84
1.23 (3.11%)
Pre Market
Last Updated: 08:26:58
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Biohaven Ltd BHVN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
1.23 3.11% 40.84 08:26:58
Open Price Low Price High Price Close Price Prev Close
39.61
more quote information »

Recent News

Date Time Source Heading
4/22/202416:05PRNUSBiohaven Announces Closing of Public Offering and Full..
4/17/202416:05PRNUSBiohaven Announces Proposed Public Offering of Common Shares
4/13/202409:00PRNUSBiohaven Showcases Innovative Neuroscience Portfolio with 20..
2/29/202416:16EDGAR2Form 8-K - Current report
2/29/202416:05PRNUSBiohaven Reports Fourth Quarter and Full Year 2023 Financial..
1/08/202407:30EDGAR2Form 8-K - Current report
1/08/202407:30PRNUSBiohaven Highlights Progress Across Innovative Portfolio and..
1/02/202407:00PRNUSBiohaven to Present at the 42nd Annual J.P. Morgan..
12/01/202316:30PRNUSBiohaven Presents Expanded EEG and Safety Data for BHV-7000..
11/14/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/14/202316:05PRNUSBiohaven Reports Third Quarter 2023 Financial Results and..
10/16/202307:00PRNUSBiohaven Presents Preclinical Data Demonstrating..
10/05/202316:05EDGAR2Form 8-K - Current report
10/05/202316:05PRNUSBiohaven Announces Closing of Public Offering and Full..
10/04/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202323:56PRNUSBiohaven Announces Pricing of $225 Million Public Offering..
10/02/202321:41EDGAR2Form 8-K - Current report
10/02/202317:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202317:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/02/202316:36PRNUSBIOHAVEN ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON SHARES
10/02/202316:01EDGAR2Form S-3ASR - Automatic shelf registration statement of..
9/27/202306:58EDGAR2Form 8-K - Current report
9/14/202307:00PRNUSBiohaven Completes Enrollment in Pivotal Phase 3 Study of..
9/05/202307:00PRNUSBiohaven Announces Positive Data from its Exploratory..
7/31/202317:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
7/31/202316:29EDGAR2Form 8-K - Current report
7/31/202309:31PRNUSBiohaven's Taldefgrobep Alfa Receives EU Orphan Drug..
7/31/202306:59PRNUSBiohaven Reports Second Quarter 2023 Financial Results and..
7/28/202316:35EDGAR2Form 8-K - Current report
7/27/202308:42DJNBiohaven Told That FDA Won't Review NDA Application for..
7/27/202307:00PRNUSBiohaven Provides Preliminary EEG Data Update for Kv7..
5/31/202307:00PRNUSBiohaven Provides Overview of Clinical Progress, Regulatory..
5/25/202317:00PRNUSBiohaven to Present R&D Day at Yale School of Management
5/12/202316:30PRNUSBiohaven Reports First Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock